MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    On-demand therapy (ODT) in Parkinson’s disease: a survey of advanced practice providers

    K. Papesh, A. Merriam, C. Zebendon (Phoenix, USA)

    Objective: A survey of neurology Advanced Practice Providers (APPs) provides insights into their perspectives on managing and treating patients with Parkinson’s disease (PD) in the…
  • 2023 International Congress

    An SNCA triplication in a Kazakhstani patient with young-onset Parkinson’s disease

    R. Kaiyrzhanov, C. Shashkin, N. Zharkinbekova, V. Akhmetzhanov, Z. Myrzayev, A. Karimova, S. Aidarov, K. Mok, H. Houlden (Shymkent, Kazakhstan)

    Objective: To report a patient with Parkinson’s disease (PD) from Kazakhstan with a rare structural defect in the SNCA gene. Background: Little is known about…
  • 2023 International Congress

    Parkinson’s disease and physiotherapy: perspectives in functional health education and innovation in digital media

    S. Souza, A. Silva, V. Israel (CURIIBA, Brazil)

    Objective: To identify and develop virtual functional health education content aimed at people with PD and to verify the reach profile on social media. Background:…
  • 2023 International Congress

    Analysis of the network of genes related to Parkinson’s and identification of key proteins

    H. Ghapani, D. Morshedi, S. Parsafar, F. Aliakbari (Tehran, Islamic Republic of Iran)

    Objective: Parkinson's disease (PD) is one of the increasing age-related diseases with no definite treatment. PD is considered as a disorder with genetic and non-genetic…
  • 2023 International Congress

    Reaching the hard-to-reach: the representativeness of patients with parkinsonism recruited to the PRIME-UK cross-sectional study

    E. Tenison, M. Smith, D. Pendry-Brazier, A. Cullen, F. Lithander, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To recruit a more representative population of patients with parkinsonism (PwP) focusing on those often excluded from  research. Background: PwP who are older, living…
  • 2023 International Congress

    Variant frequencies in dystonia and Parkinson’s disease genes cross phenotypic boundaries

    L. Lange, A. Illarionova, K. Grütz, EJ. Vollstedt, B-H. Laabs, S. Löns, G. Kilic-Berkmen, F. Hinrichs, H. Padlock, L. Screven, T. Bäumer, H. Jinnah, N. Brüggemann, Z-H. Fang, K. Lohmann, C. Klein (Luebeck, Germany)

    Objective: To investigate the frequency of genetic variants in dystonia (DYT) genes in patients with PD and vice versa. Background: The impact of genetic variants…
  • 2023 International Congress

    Sex differences for off episodes in Parkinson’s disease

    A. Ratnavel, C. Jiang, A. Liu, K. Wang, A. Tsai, K. Wyman-Chick, E. Bayram (La Jolla, USA)

    Objective: To determine the sex differences for the frequency, duration, and impact of off episodes in Parkinson’s disease (PD). Background: Dopamine replacement therapy through oral…
  • 2023 International Congress

    Multi-stakeholder focus group study to develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease

    QY. Tan, S. Fraser, H. Roberts, K. Ibrahim (Southampton, United Kingdom)

    Objective: To develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease (PD) Background: Our research has identified potentially modifiable factors of…
  • 2023 International Congress

    Contribution of MRI and machine learning approaches to the diagnosis of patients with early-stage parkinsonism in a situation of clinical uncertainty

    L. Chougar, A. Faucher, J. Faouzi, FX. Lejeune, F. Cormier, M. Vidailhet, O. Colliot, S. Lehericy, D. Grabli, B. Degos (PARIS, France)

    Objective: To determine whether MRI and machine learning approaches improve diagnostic accuracy in patients with early-stage parkinsonism compared to clinical criteria Background: Parkinson’s disease (PD)…
  • 2023 International Congress

    Ethnic and Gender Disparities in Access to Deep Brain Stimulation for Parkinson’s Disease Among Participants in C-OPN

    I. Ojo, S. Poonja, J. Miyasaki, A. Shetty, T. Sankar, F. Ba (Edmonton, Canada)

    Objective: To study the disparities in gender and ethnicity and the related contributing factors in Parkinson’s disease (PD) patients who require deep brain stimulation (DBS),…
  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley